ReviewOncotarget2017
BET inhibitors as novel therapeutic agents in breast cancer.
Alberto Ocaña et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
26 papers cite it
this papertrialcites it
ReviewOncotarget2017
Alberto Ocaña et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.